We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » OIG Calls for New FDA Emergency Use Authorization Policy for Tests
OIG Calls for New FDA Emergency Use Authorization Policy for Tests
The FDA needs to revise its Emergency Use Authorization (EUA) policies for tests of future infectious disease outbreaks, the HHS Office of Inspector General recommends in a new report.